Document is current
Any future updates will be listed below
-
Authors
Chokshi, Chirayu R. http://orcid.org/0000-0003-0831-0217
Shaikh, Muhammad Vaseem
Brakel, Benjamin
Rossotti, Martin A.
Tieu, David
Maich, William
Anand, Alisha
Chafe, Shawn C.
Zhai, Kui
Suk, Yujin
Kieliszek, Agata M.
Miletic, Petar
Mikolajewicz, Nicholas http://orcid.org/0000-0002-7525-0384
Chen, David
McNicol, Jamie D.
Chan, Katherine http://orcid.org/0009-0000-7513-5880
Tong, Amy H. Y.
Kuhlmann, Laura
Liu, Lina
Alizada, Zahra
Mobilio, Daniel
Tatari, Nazanin
Savage, Neil
Aghaei, Nikoo
Grewal, Shan
Puri, Anish
Subapanditha, Minomi
McKenna, Dillon
Ignatchenko, Vladimir
Salamoun, Joseph M.
Kwiecien, Jacek M.
Wipf, Peter http://orcid.org/0000-0001-7693-5863
Sharlow, Elizabeth R.
Provias, John P.
Lu, Jian-Qiang http://orcid.org/0000-0003-1945-5569
Lazo, John S. http://orcid.org/0000-0002-0645-4025
Kislinger, Thomas http://orcid.org/0000-0003-3525-5540
Lu, Yu
Brown, Kevin R.
Venugopal, Chitra
Henry, Kevin A.
Moffat, Jason http://orcid.org/0000-0002-5663-8586
Singh, Sheila K. http://orcid.org/0000-0003-1272-5300
-
Funding
Funding for this research was provided by:
Terry Fox Research Institute (1065, 1065, 1065)
Mitacs (IT15477, IT11823)
Foundation for the National Institutes of Health (R43 CA228774, P30 CA044579)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-438323)
- License Information
-
More Information
Article History
Received: 3 August 2023
Accepted: 18 June 2024
First Online: 2 August 2024
Competing interests
: J.S.L., P.W., J.M.S. and E.R.S. are co-inventors of US patent no. 10,308,663, which describes the chemical synthesis, composition of matter and use of JMS-053 for the treatment of cancer. J.S.L., P.W. and E.R.S. are co-founders of KeViRx, Inc., which has licensed the above-mentioned intellectual property from the University of Virginia and the University of Pittsburgh for further development. All other authors declare no competing interests.
